Literature DB >> 31047116

Bronchodilators in subjects with asthma-related comorbidities.

Mario Cazzola1, Paola Rogliani2, Luigino Calzetta2, Maria Gabriella Matera3.   

Abstract

Asthma is often associated with different comorbidities such as cardiovascular diseases, depression, diabetes mellitus, dyslipidaemia, osteoporosis, rhinosinusitis and mainly gastro-oesophageal reflux disease and allergic rhinitis. Although bronchodilators play an important role in the treatment of asthma, there is no overall description of their impact on comorbid asthma, regardless of whether favourable or negative. This narrative review examines the potential effects of bronchodilators on comorbidities of asthma.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Asthma; Comorbidities; Muscarinic agonists; Xanthines; β(2)-agonists

Mesh:

Substances:

Year:  2019        PMID: 31047116     DOI: 10.1016/j.rmed.2019.04.001

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  3 in total

1.  Efficacy and safety of Chinese medicines for asthma: A systematic review protocol.

Authors:  Qi Shi; Dongxu Si; Haipeng Bao; Yue Yan; Yanhua Kong; Chunlei Li; Wenfeng He; Dashzeveg Damchaaperenlei; Mingxia Yu; Youlin Li
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

2.  Meta-Analysis of the Association Between Asthma and the Risk of Stroke.

Authors:  Zheng-Hua Fang; Zhi-Fei Li; Zhuo-Yu An; Si-Cheng Huang; Meng-Di Hao; Wei-Xing Zhang
Journal:  Front Neurol       Date:  2022-06-24       Impact factor: 4.086

3.  Transcriptomic Analysis Exploring the Molecular Mechanisms of Hanchuan Zupa Granules in Alleviating Asthma in Rat.

Authors:  Hailong Yin; Yanbo Fan; Dandan Mu; Fei Song; Fang Tian; Qiang Yin
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-02       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.